Search

everythinglearnresearchcommunity

for

Search:↓

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

BPH management needs better long-term studies and prevention strategies.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

The PML protein helps prevent skin cancer in mice.

PLD is an effective and safer alternative for treating breast cancer.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Certain medications can cause serious side effects, so it's important to report them.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.